Scientists create genetic ‘pen’ that corrects common heart conditions
By Manuel Ansede,
El País
| 01. 15. 2023
The gene editing techniques that have revolutionized medicine since 2016 could also be used to treat common heart diseases, the number one cause of death in humans, according to a study published recently by one of the world’s leading scientists, Eric Olson, from the US. His team was able to modify two letters – or bases – of the approximately 3 billion that make up the DNA of a mouse. This change was enough to silence a protein linked to multiple cardiovascular problems. Olson is cautious, but highlights the potential advantages of this new strategy: since heart cells last a lifetime, it is only a matter of making the change once.
DNA is like a recipe book for making proteins, the minuscule machines that take care of the main tasks in a living being: carrying oxygen through the blood, fighting viruses, digesting food. That manual is written with four letters, repeated millions of times: ATGGCGAGTTGC… each of these letters is the initial of a chemical compound with different amounts of carbon, hydrogen, nitrogen and oxygen: adenine (C₅H₅N₅), cytosine (C₄H₅N₃O)...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...